Coronavirus, COVID, Infection Viral
Conditions
Keywords
pediatric emergencies, pandemia
Brief summary
Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.
Interventions
DIAGNOSTIC_TESTnasopharyngeal swab
Data collection and nasopharyngeal swab
Sponsors
University Hospital, Lille
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No
Inclusion criteria
* 1st Line Consultation in Pediatric Emergencies * All reasons for consultation during working hours * Informed and written consent of a parent holder (only 1 authorized companion) and a child of understanding age
Exclusion criteria
* Refusal of participation by parents/child of decision age * No membership of a social security scheme (beneficiary or entitled) * No understanding of French
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of positivity of COVID-19 virus measured by rt-PCR | At 28 days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of positivity of COVID-19 virus measured by rt-PCR in the following subpopulations of emergency patients | at the end an average 28 days | children admitted to pediatric emergencies for respiratory signs * Children hospitalized as a result of travelling to pediatric emergency departments for respiratory signs * Respiratory asymptomatic children admitted to pediatric emergencies |
| Respiratory signs of children tested within 28 day | through study completion, an average 28 days | — |
| Percentage of children hospitalized tested within 28 day | through study completion, an average 28 days | — |
| Contact frequency | At inclusion | the degree of relationship with these contacts and the time spent in contact with them within 24 hours before emergency |
| Prevalence of positivity of other respiratory viruses measured by rt-PCR | at 28 days | — |
Countries
France
Outcome results
None listed